Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

[A prospective study to assess the burden of influenza-related hospitalizations and emergency department visits among children in Bilbao, Spain (2010-2011)].

Ortiz-Lana N, Garrote E, Arístegui J, Rementeria J, García-Martínez JA, McCoig C, García-Corbeira P, Devadiga R, Tafalla M.

An Pediatr (Barc). 2017 Dec;87(6):311-319. doi: 10.1016/j.anpedi.2016.10.016. Epub 2017 Mar 28. Spanish.

2.

Multicenter prospective study on the burden of rotavirus gastroenteritis in children less than 3 years of age in Spain.

Arístegui J, Ferrer J, Salamanca I, Garrote E, Partidas A, San-Martin M, San-Jose B.

BMC Infect Dis. 2016 Oct 10;16(1):549.

3.

A short in-frame deletion in NTRK1 tyrosine kinase domain caused by a novel splice site mutation in a patient with congenital insensitivity to pain with anhidrosis.

Sarasola E, Rodríguez JA, Garrote E, Arístegui J, García-Barcina MJ.

BMC Med Genet. 2011 Jun 27;12:86. doi: 10.1186/1471-2350-12-86.

4.

Automated home-cage behavioural phenotyping of mice.

Jhuang H, Garrote E, Mutch J, Yu X, Khilnani V, Poggio T, Steele AD, Serre T.

Nat Commun. 2010 Sep 7;1:68. doi: 10.1038/ncomms1064. Erratum in: Nat Commun. 2012;3. doi: 10.1038/ncomms1399. Mutch, Jim [added].

PMID:
20842193
5.

Reduction in pediatric invasive pneumococcal disease in the Basque Country and Navarre, Spain, after introduction of the heptavalent pneumococcal conjugate vaccine.

Aristegui J, Bernaola E, Pocheville I, García C, Arranz L, Durán G, Pérez L, Bastida M, Canduela C, Herranz Aguirre M, Garrote E, Fletcher MA, Pérez C.

Eur J Clin Microbiol Infect Dis. 2007 May;26(5):303-10.

PMID:
17457623
6.

Interferon alpha treatment of chronic hepatitis C in HIV-infected patients receiving zidovudine: efficacy, tolerance and response related factors.

Del Pozo MA, Arias JR, Pinilla J, Labarga P, Alcoba M, Martinez de la Cruz FJ, Anton F, Carro JA, Perez MR, Echevarria S, Garrote E, Moreno-Otero R.

Hepatogastroenterology. 1998 Sep-Oct;45(23):1695-701.

PMID:
9840131
8.

Immune response to a combined hepatitis B, diphtheria, tetanus and whole-cell pertussis vaccine administered to infants at 2, 4 and 6 months of age.

Aristegui J, Garrote E, González A, Arrate JP, Perez A, Vandepapelière P.

Vaccine. 1997 Jan;15(1):7-9.

PMID:
9041659
9.

Safety and immunogenicity of an inactivated hepatitis A vaccine in children 2 to 5 years old.

Arístegui J, Morales JL, Dal-Ré R, González A, Gallego MS, Garrote E.

Infection. 1995 Sep-Oct;23(5):334-8.

PMID:
8557400

Supplemental Content

Loading ...
Support Center